Ormat Technologies director exercises 1,315 options
The option exercise was settled directly with the issuer, with 966 shares deducted from the shares issued to pay the exercise price.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
On November 2, 2026, ORMAT Technologies, Inc. director Stanley Stern exercised stock options for 1,315 shares at an exercise price of $67.54 per share. He received 1,315 common shares, while 966 shares were withheld to pay the exercise price. The transaction was between Stern and the company and did not involve a market sale. His reported option position following the exercise was 0.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F1 | 1,315 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 1,315 | $67.54 | $89K |
| Exercise Price Payment | Common Stock F1 | 966 | $91.87 | $89K |
Footnotes (1)
- F1. Represents the exercise of stock options expiring on November 4, 2026, for which the exercise price was paid via a reduction in the number of shares issued to the reporting person by the value of the exercise price. The transaction was between the reporting person and the issuer, and did not involve a sale or other transaction with the market
Key Figures
Key Terms
Stock Option (Right to Buy) technical
exercise price financial
derivative security technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many ORA options did Stanley Stern exercise?
How was Stanley Stern’s ORA option exercise settled?
AI-generated analysis. How Rhea-AI works. Not financial advice.